INTRODUCTION
Phenolic compounds have been receiving increasing interest from consumers and manufacturers because numerous epidemiological studies have suggested associations between consumption of polyphenol-rich foods or beverages and the prevention of certain chronic diseases such as cancers and cardiovascular diseases. Cardiovascular disease (CVD), in particular coronary heart disease and stroke, is a major cause of mortality in developed nations [1] .CVD is a chronic, multi-factorial disease in which a range of genetic and environmental factors plays a role in its initiation, progression and development [2] . Numerous epidemiological and human intervention studies have suggested that regular consumption of polyphenol-rich foods, such as fruits, vegetables, cocoa, tea and wine, may exert cardio-protective effects in humans [3] . Resveratrol, a dietary polyphenol may play an important role in this phenomenon. Research activities have been focused on cardioprotection by grape-derived resveratrol, in large part to address the correlation between intake of resveratrol and a reduced risk of Cardiovascular disease.
RESVERATROL
Resveratrol (3,5,4'-trihydroxy-trans stilbene) is a stilbenoid, a type of natural phenol, and a phytoalexin produced naturally by several plants when under attackby pathogens such as bacteria or fungi. Resveratrol is important in plant biology because it serves as parent molecule for a family of polymers known as viniferin. These compounds are able to inhibit the progress of fungal infections in plants [4] . Resveratrol exists as two geometric isomers: cis-(Z) and trans-(E) as shown in Figure 1 .
Figure 1. cis and trans isomers of resveratrol
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However trans-resveratrol is the preferred steric form and is relatively stable if protected from high pH and light , it is the commonly studied form of resveratrol as reported by most laboratories [5] . The trans-and cis-resveratrol can be either free or bound to glucose [6] .
The trans-form can undergo isomerisation to the cis-form when exposed to ultraviolet irradiation, a process called photoisomerization [7] .
Figure 2. Resveratrol isomerization
Resveratrol is reported to have numerous biological properties and implications for human health and disease [5] . [5] 
SOURCES OF RESVERATROL
Resveratrol has been detected in trees, in a few flowering plants, in peanuts, and in grapevines. The major dietary sources of resveratrol include grapes, wine, peanuts, and peanut products [8] . Fresh grape skins contain 50 to 100 mg resveratrol per gram [5] . Red wine contains between 0.2 and 5.8 mg/l [9] , depending on the grape variety, while white wine has much less, because red wine is fermented with the skins, allowing the wine to extract the resveratrol, whereas white wine is fermented after the skin has been removed [10] .
The composition of wine is different from that of grapes since the extraction of resveratrols from grapes depends on the duration of the skin contact, and the resveratrol 3-glucosides are in part hydrolysed, yielding both trans-and cis-resveratrol. Muscadine grapes contain high levels of resveratrol, with multiple cardioprotective effects. These antioxidants are thought to be the effective agents behind the so-called,French Paradox, the low mortality rate from CAD amongst the French population despite their high-fat diet and smoking [11] . The concentration of resveratrol present in peanuts is dependent upon many different factors. Cultivar, growing season, weather conditions, and peanut maturity have been shown to affect resveratrol concentrations [12] .
RESVERATROL AS A CARDIOPROTECTIVE AGENT:
Inflammation plays a major role in the pathogenesis of a wide variety of diseases including cardiovascular diseases, cancer, diabetes, Alzheimer's disease, and autoimmune diseases. Agents that can suppress inflammation thus have a potential in mitigating the symptoms of the disease.
Resveratrol exhibits antioxidant and antiinflammatory activities and thus may have potential in the treatment of these diseases. [13] Resveratrol plays an import role in maintaining stationarity of the cardiovascular system. The risk factors colored gray make coronary atherosclerosis, myocardial ischemia, and end-stage heart failure happen. Resveratrol, by interrupting these factors and events, may be possible to prevent or slow the de velopment of cardiovascular disease. In addition, resveratrol at lower dose prolongs cardiomyocytes survival in failing hearts, enhances angiogenesis under postischemic conditions, and improves cardiac stem cells homing, proliferation, and differentiation, thus may be possible to reverse heart dysfunction [13] .
Figure 4. Multiple targets of resveratrol in cardiovascular disease
It achieves the effects by the following functions.
RESVERATROL INHIBITS PLATELET ACTIVATION AND AGGREGATION
Platelet activation has been shown to play a critical role in the pathogenesis of CAD-related complications [5] . Platelets are cells without nuclei that are made in the bone marrow and function to stop bleeding via aggregation at the wound site. Platelets can be activated by several different factors, including adenosine diphosphate (ADP), collagen, and thrombin. When activated platelets change morphology they aggregate and seal damaged blood vessels. Excessive aggregation can lead to the development of cardiovascular disease. Pretreatment of platelets with resveratrol has been shown to inhibit lipopolysaccharide (LPS) and LPS + thrombin-stimulated platelet adhesion to collagen and fibrinogen in a non-dose-dependent manner [14] Wang and others demonstrated that rabbits receiving resveratrol supplementation had reduced rates of platelet aggregation when fed a high cholesterol diet. Importantly, resveratrol did not change total plasma LDL levels in this study [15] . Wang's study is consistent with the findings by other investigators that resveratrol inhibited the activation and aggregation of platelets in response to thrombin, ADP, and collagen, probably through the blockade of thromboxane B2 synthesis [16] . Wang's study suggests that resveratrol administration may positively modify the outcomes of these clinical conditions.
RESVERATROL IN VASORELAXATION
The cardioprotective effects of resveratrol may also be due, in part, to its vasorelaxation properties. Chen and Pace-Asciak [17] examined the vasorelaxation effect of resveratrol on rat aortic rings with and without intact endothelium. Pretreatment with resveratrol resulted in a dose-related decrease in noradrenaline (NA)-and phenylephrine (PE)-induced contraction in endothelium-intact rat aortic rings. Endothelium-independent rings required higher concentrations of resveratrol before relaxation was observed. The authors concluded that resveratrol mediates vasorelaxation in endothelium-intact and endothelium-independent aortic rings via nitric oxide-dependent andindependent mechanisms, respectively. 
RESVERATROL IN LIPID METABOLISM
Considerable evidence suggests that oxidation of low-density lipoprotein (LDL) is a crucial step in the pathogenesis of atherosclerosis. Dietary antioxidants that can inhibit LDL oxidation are receiving considerable attention for their role in the prevention of coronary heart disease. LDL contains phospholipids, free and esterified cholesterol, triacylglycerols, and amino acids, which form apolipoprotein B. The proteins and the polyunsaturated fatty acids components of the LDL are susceptible to free radical-mediated oxidation, particularly if the antioxidant content of the LDL is low. When LDL is oxidized in vitro, there is a loss of polyunsaturated fatty acids yielding a range of fragments including hydroperoxides, aldehydes and ketones, which conjugate with other LDL-bound lipids and the apolipoprotein B. This minimally modified LDL has a number of properties that could increase its atherogenecity [11] . Figure 5 . Resveratrol and cholesterol metabolism [13] Resveratrol reduces cholesterol synthesis by downregulating HMG-CoA reductase. Resveratrol also enhances reverse cholesterol transport/cholesterol excretion through increasing HDL levels and the capacity of HDL to mediate cholesterol efflux from macrophages in arterial walls.
CETP is a plasma glycoprotein that facilitates the transfer of cholesteryl esters from the atheroprotective HDL to the proatherogenic LDL and VLDL [18] and resveratrol has been shown to inhibit the activity of CETP. Furthermore, adipocytes store cholesterol and have proatherogenic effects. Resveratrol can prevent adipogenesis and plays a role in dyslipidemia and obesity. LDL lowdensity lipoprotein, CE cholesteryl ester, CETP cholesteryl ester transfer protein, HDL high-density lipoprotein, VLDL very-low-density lipoprotein [13] .
Resveratrol was assumed to protect against atherosclerosis by reducing the peroxidative degradation of LDL. The in vitro effectiveness of resveratrol was thought to be mainly due to its capacity to chelate copper, although it also scavenges free radicals. Resveratrol is more effective than butylhydroxytoluene (BHT), quercetin or tocopherol on lipid peroxidation in liposomes and in rat liver. Resveratrol can inhibit LDL oxidation and it mainly acts by reducing the copper-catalyzed oxidation, while flavonoids are better scavengers of free radicals [11] .
ANTI-AGING EFFECTS OF RESVERATROL
Aging is a risk factor of cardiovascular diseases. To slower the speed of aging and prevent the occurrence of age associated chronic diseases is a key issue in modern society. Resveratrol can activate anti-aging genes and facilitate extending lifespan in lower organisms like yeasts and worms [19] . Resveratrol also increase survival of thehigh-calorie-diet-fed mice. However, adding resveratrol to mice fed with a normal diet did not affect the overall survival or maximum lifespan, suggesting that resveratrol might be counteracting the negative consequences of obesity and insulin resistance, thus slowing aging [19] .
CLINICAL TRIALS
Resveratrol is a food supplement for eliminating free radical and keeping healthy, but it is not into a clinical stage yet currently. Resveratrol has a short initial half-life (*8-14 min for the primary molecule) and is extensively metabolized in the body. Blocking the metabolism of resveratrol, developing analogs with improved bioavailability, or searching for new and more potent compounds that mimic its effects will become increasingly important [20] . Fortunately, research on the structure of resveratrol is ongoing [21] . Screening the effective elements of resveratrol in vivo and determining the differences between in vivo and in vitro results are challenge for researchers.
CONCLUSION
Resveratrol is reported to have numerous biological properties and implications for human health and disease. However, given its low levels in food sources including red wine, it is unlikely that desired biological endpoints will be achieved from normal dietary consumption.
In addition, further understanding of the potential toxicity, health effects, bioavailability, and metabolism of resveratrol is necessary before dietary and supplement recommendations can be made.
